TITLE

Recurrent disease in renal allografts

AUTHOR(S)
Cameron, J. Stewart
PUB. DATE
October 1993
SOURCE
Kidney International Supplement;Oct1993, Issue 43, pS91
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Recurrent or de novo diseases account for only 5% of graft failure in children, but have much to teach us about mechanisms. In children, almost the only metabolic disease with recurrence is type I hyperoxaluria, in which the poor long-term results of isolated renal transplantation makes combined liver and renal transplantation, or even prophylactic liver transplantation before renal failure the preferable alternative. While many forms of nephritis may show histological recurrence in allografts, it is notable that in many patients this is accompanied no clinical manifestations or only mild disease; this is particularly so in MCGN type II, IgA-associated nephropathy and Schönlein-Henoch purpura. However, FSGS and MCGN type I recur with frequency and severity. Hemolytic-uremic syndromes may recur, even repeatedly, but this is unusual. As many as 10% of pediatric grafts may show de novo membranous nephropathy, but in the majority this is mild or not clinically evident. In contrast, the rare anti-GBM nephritis affecting some patients with Alport's syndrome usually results in graft failure, but occurs in only a minority of Alport recipients. For all types of disease in allografts, risk factors for recurrence are poorly worked out, and attempts at treatment generally ineffective.
ACCESSION #
20486301

 

Related Articles

  • Calciphylaxis in pediatric end-stage renal disease. Imam, Abubakr A.; Mattoo, Tej K.; Kapur, Gaurav; Bloom, David A.; Valentini, Rudolph P. // Pediatric Nephrology;Dec2005, Vol. 20 Issue 12, p1776 

    Calciphylaxis is a rare, but life-threatening complication of end-stage renal disease (ESRD) that has been reported mostly in adult patients. The exact etiology is unknown, but the disease is commonly associated with a high calcium-phosphorus product and elevated levels of parathyroid hormone...

  • Validity of cystatin C/creatinine ratio in pediatric kidney disease. Park, Se; Shin, Jae // Clinical & Experimental Nephrology;Oct2012, Vol. 16 Issue 5, p814 

    No abstract available.

  • Predictors of growth response to rhGH in short children before and after renal transplantation. Wuhl, Elke; Haffner, Dieter; Tonshoff, Burkhard; Mehls, Otto // Kidney International Supplement;Oct1993, Issue 43, pS76 

    Many children with chronic renal failure (CRF) present with a reduced height and a reduced height velocity resulting in diminished final height irrespective of renal replacement therapy. Recombinant human growth hormone (rhGH) has become a new treatment modality for short renal patients, and the...

  • CHRONIC RENAL FAILURE IN CHILDREN; ETIOLOGY AND CLINICAL PRESENTATION. Sajid, Nisar Khan; Ahmad, Shakil; Sarwar, Imran // Professional Medical Journal;2014, Vol. 21 Issue 2, p280 

    Introduction: Chronic renal failure is defined as progressive and irreversible loss of renal functions that gradually progress to end-stage renal disease. The etiology of chronic renal failure in childhood correlates closely with the age of patient at the time when the renal failure is first...

  • Growth and development of nondialyzed children with chronic renal failure. Kleinknecht, Claire; Broyer, Michel; Huot, Danièle; Marti-Henneberg, Carles; Dartois, Anne-Marie // Kidney International Supplement;Nov1983, Issue 15, pS-40 

    Thirty-four children with severe kidney disease, either congenital (32 cases) or developing at birth, were followed until age 5 to 19 years. Overall growth retardation corresponded to −2.5 SD below the mean normal values. The retardation occurred almost exclusively before therapy for it...

  • Worldwide demographic aspects of chronic renal failure in children. Gusmano, Rosanna; Perfumo, Francesco // Kidney International Supplement;Jun1993, Issue 41, pS-31 

    Incidence of chronic renal failure in children is not yet clearly known. In recent years it has been evaluated on the basis of the number of patients accepted into dialysis-transplantation programs and is thus underestimated, as registries do not list children who are not treated for technical...

  • Antenatal oligohydramnios of renal origin: long-term outcome. Ilka Klaassen; Thomas J. Neuhaus; Dirk E. Mueller-Wiefel; Markus J. Kemper // Nephrology Dialysis Transplantation;Feb2007, Vol. 22 Issue 2, p432 

    Background. Prognosis of fetuses with renal oligohydramnios (ROH) is often still regarded as poor. Neonatal complications and the long-term follow-up of fetuses with ROH in two pediatric centres are described.Method. 23 fetuses (16 males, 7 females) were included as patients. Primary diseases...

  • Clinical outcome of children with chronic kidney disease in a pre-dialysis interdisciplinary program. Bouissou Soares, Cristina M.; Diniz, José Silvério S.; Lima, Eleonora M.; Penido Silva, Jose M.; Oliveira, Gilce R.; Canhestro, Monica R.; Colosimo, Enrico A.; Simoes e Silva, Ana Cristina; Oliveira, Eduardo A. // Pediatric Nephrology;Nov2008, Vol. 23 Issue 11, p2039 

    The purpose of this retrospective cohort study was to describe the outcome of 107 patients with chronic kidney disease (CKD) admitted to a pre-dialysis interdisciplinary management program from 1990 to 2006. The events of interest were progression to CKD stage 5 (renal survival), patient...

  • Stimulating growth in uremic children. Fine, Richard N. // Kidney International;Jul1992, Vol. 42 Issue 1, p188 

    Reports on a case of a four-year-old boy who has been diagnosed with renal insufficiency secondary to bilateral renal dysplasia. Manifestations of the condition; Formula recommended as dietary supplement for the boy; Factors causing growth retardation in children with chronic renal failure;...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics